Niraparib Efficacy and Safety in Patients With BRCA-Mutated Ovarian Cancer: Results From Three Phase 3 Niraparib Trials

[Anonymous]

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021; 19 (8): 7